Caro, Jessica
Braunstein, Marc
Williams, Louis
Bruno, Benedetto
Kaminetzky, David
Siegel, Ariel
Razzo, Beatrice
Alfandari, Serge
Morgan, Gareth J. http://orcid.org/0000-0002-4271-6360
Davies, Faith E.
Boyle, Eileen M. http://orcid.org/0000-0001-8791-1744
Article History
Received: 2 November 2021
Revised: 20 December 2021
Accepted: 23 December 2021
First Online: 2 February 2022
Competing interests
: Jessica Caro: None. Marc Braunstein: Research Support – Janssen, Celgene; Advisory: ADC Therapeutics, Amgen, AstraZeneca, Celgene, Epizyme, Janssen, Karyopharm, Morphosys, Pfizer, Takeda, TG Therapeutics, Verastem; Faculty Bureau: Janssen. Louis Williams: None. Benedetto Bruno: None. David Kaminetzky: None. Ariel Siegel: None. Beatrice Razzo: None. Serge Alfandari: None. Gareth J Morgan: Janssen – research funding; Bristol-Myers Squibb – consultancy, honoraria; Takeda – consultancy, honoraria; Celgene Corporation – consultancy, honoraria, research funding; Roche – consultancy, honoraria; Amgen – consultancy, honoraria; GSK – consultancy, honoraria; Karyopharm – consultancy, honoraria. Faith E Davies: Adaptive – honoraria; Celgene Corporation – consultancy, honoraria, research funding; Janssen – consultancy, honoraria; Oncopeptide - consultancy, honoraria; Roche – consultancy, honoraria; Sanofi - consultancy, honoraria; Takeda – consultancy, honoraria. Eileen M Boyle: None.
Free to read: This content has been made available to all.